160 likes | 563 Views
HOPE-TOO: Rationale. HOPE-TOO was an extension of the HOPE trial, which examined the effects of ACE inhibition in reducing major CV events in high-risk patients with vascular disease or diabetes HOPE-TOO was designed to assess whether the CV and metabolic benefits of ramipril were sustained over t
E N D